Rabbit Anti-thymocyte Globulin (rATG) as Induction Immunosuppression Therapy in Patients Undergoing Renal Transplantation: Clinical Experience from RISE Registry

• Published in: Indian journal of transplantation Vol. 17; no. 3; pp. 294 - 300
• Main Authors: Ray, Deepak Shankar, Gang, Sishir, Khullar, Dinesh, Bhalla, Anil Kumar, Sharma, Ashish, Abraham, Abi, Raju, Sree Bhushan, Siddhi, Vishwanath, Dutta, Arup R., Abraham, Georgie, Shekar, M Soma, Shah, Bharat V., Kothari, Jatin, Bahadur, Madan, Ahmed, Ishtiaque, Narula, Ajit Singh, Margabandhu, Sarvanan, Shetty, Sujatha, Chodankar, Deepa, Mandrekar, Aniket, Salvi, Vaibhav Shrikant
• Format: Journal Article
• Language: English
• Published: India Wolters Kluwer - Medknow 01.07.2023; Medknow Publications and Media Pvt. Ltd; Wolters Kluwer Medknow Publications
• Edition: 2
• Subjects: acute rejection; adverse event; Antithymocyte globulin; Care and treatment; graft rejection; Immunotherapy; induction; Kidneys; Medical research; Medicine, Experimental; Original Article; Pharmaceutical industry; pyrexia; Transplantation; Type 2 diabetes; France; India; Acute rejection; adverse event; graft rejection; induction; pyrexia

Introduction: Induction immunosuppression therapy plays a significant role in the prevention of acute rejection in renal transplantation. This study aimed to evaluate the effectiveness and safety of rabbit anti-thymocyte globulin (rATG) used as induction immunosuppression in Indian patients undergoi...